Ashley Kaplowitz | executive |
Barry Greene | executive |
Chris Benecchi | executive |
Laura Gault | executive |
Kimi Iguchi | executive |
Ritu Baral | analyst |
Anupam Rama | analyst |
Tazeen Ahmad | analyst |
Salveen Richter | analyst |
Jay Olson | analyst |
Leonid Timashev | analyst |
Paul Matteis | analyst |
Ami Fadia | analyst |
George Farmer | analyst |
Sumant Kulkarni | analyst |
Laura Chico | analyst |
Good morning. Welcome to Sage Therapeutics' Third Quarter 2023 Conference Call. [Operator Instructions] This call is being webcast live on the Investors and Media section of Sages' website at sagerx.com. This call is the property of Sage Therapeutics and recording, reproduction or transmission of this call without the express written consent of Sage Therapeutics is strictly prohibited. Please note this call is being recorded.I would now like to introduce Ashley Kaplowitz, Director of Investor Relations at Sage.